Compare DigitalOcean Holdings Inc (DOCN) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DigitalOcean Holdings Inc vs IDEXX Laboratories, Inc. — how do they compare? DigitalOcean Holdings Inc trades at $135.42 (market cap $14.57B), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 2.8× DigitalOcean Holdings Inc's market cap, and DigitalOcean Holdings Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DigitalOcean Holdings Inc for 43 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| DOCN | IDXX | |
|---|---|---|
Market Cap | $14.57B | $40.43B |
Volume | 2,261,786 | 692,164 |
Sector | Technology | Health |
52-Week High | $181.29 | $766.68 |
52-Week Low | $37.30 | $504.70 |
Typical Hold Time | 43 Days | 46 Days |
Enterprise Value | $15.33B | $41.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DigitalOcean (DOCN) trades at $132.70, up 4.26% today, showing strong momentum after recent earnings beats. The stock demonstrates robust fundamental performance with 29% revenue growth in Q2 2026 and impressive profitability metrics including 57.22% gross margin and 23.27% net margin. Technical indicators show bullish momentum with RSI levels suggesting potential oversold conditions, while the stock trades below the consensus price target of $172.73. Recent news highlights the company's strategic focus on AI-native cloud services with new product launches and a $725 million equipment financing facility.
DOCN presents a compelling growth story with strong AI-driven revenue acceleration and consistent earnings outperformance. However, elevated valuation multiples (P/E 56.32, P/S 13.96) and negative shareholder equity pose significant risks. The company's aggressive expansion strategy requires careful monitoring of cash flow sustainability amid substantial capital expenditures.
IDEXX Laboratories (IDXX) trades at $519.87, up 2.61% on the day, with a bearish technical signal from moving averages but strong fundamentals including a 25.03% net income margin and consistent earnings beats. Revenue grew to $4.3B in 2025, and the company recently acquired CoVetAI to enhance veterinary workflow intelligence, signaling strategic expansion.
The stock's outlook is supported by robust profitability and analyst consensus, but faces headwinds from technical weakness and potential market volatility. With a $665 price target implying significant upside, the primary risks include competitive pressures and execution of growth initiatives amid economic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About DigitalOcean Holdings Inc
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.
Read more on DOCN →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
